Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Exploratory/Developmental Cooperative Agreement Phase I (UH2)
Project #
4UH2HL123886-03
Application #
9323083
Study Section
Special Emphasis Panel (ZHL1-CSR-A (M1))
Program Officer
Freemer, Michelle M
Project Start
Project End
Budget Start
2016-08-19
Budget End
2017-06-30
Support Year
3
Fiscal Year
2016
Total Cost
$357,958
Indirect Cost
$193,757

  Institution

Name
Yale University
Department
Type
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520

  Publications

Yu, Guoying; Tzouvelekis, Argyris; Wang, Rong et al. (2018) Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function. Nat Med 24:39-49
Tzouvelekis, Argyris; Herazo-Maya, Jose D; Slade, Martin et al. (2017) Validation of the prognostic value of MMP-7 in idiopathic pulmonary fibrosis. Respirology 22:486-493
Kass, Daniel J; Kaminski, Naftali (2017) Time to share: lessons from post hoc analyses of IPF trials. Thorax 72:101-102
Herazo-Maya, Jose D; Sun, Jiehuan; Molyneaux, Philip L et al. (2017) Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study. Lancet Respir Med 5:857-868
Brownell, Robert; Kaminski, Naftali; Woodruff, Prescott G et al. (2016) Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med 193:1213-8